Clinical response to omalizumab in patients with hereditary α-tryptasemia

Ann Allergy Asthma Immunol. 2020 Jan;124(1):99-100.e1. doi: 10.1016/j.anai.2019.09.026. Epub 2019 Oct 9.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Humans
  • Mastocytosis / drug therapy*
  • Mastocytosis / genetics
  • Omalizumab / therapeutic use*
  • Pruritus / drug therapy*
  • Pruritus / genetics
  • Treatment Outcome
  • Tryptases / blood
  • Tryptases / genetics*
  • Urticaria / drug therapy*
  • Urticaria / genetics

Substances

  • Anti-Allergic Agents
  • Omalizumab
  • TPSAB1 protein, human
  • Tryptases